MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$20,366K
EPS
-$0.32
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
-0* --
Research and development
13,584 35,389* 17,938 32,198
General and administrative
8,188 11,629* 10,331 13,394
Total operating expenses
21,772 47,017* 28,269 45,592
Loss from operations
-21,772 -47,017* -28,269 -45,592
Interest and other income (expense), net
1,732 2,590* 2,783 3,101
Interest expense
0 123* 815 809
Loss on extinguishment of debt (note 7)
--457* --
Net loss
-20,040 -45,007* -26,301 -43,300
Net unrealized (loss) on short-term investments
-326 -84 35 -160
Total other comprehensive loss
--84* --
Comprehensive loss
-20,366 -45,091 -26,266 -43,460
Basic EPS
-0.32 -0.735 -0.43 -0.71
Diluted EPS
-0.32 -0.735 -0.43 -0.71
Basic Average Shares
61,803,467 61,308,003 61,406,475 61,386,183
Diluted Average Shares
61,803,467 61,308,003 61,406,475 61,386,183
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$20,366K Net loss-$20,040K Net unrealized(loss) on short-term...-$326K Interest and other income(expense), net$1,732K Loss from operations-$21,772K Total operatingexpenses$21,772K Research and development$13,584K General andadministrative$8,188K

PLIANT THERAPEUTICS, INC. (PLRX)

PLIANT THERAPEUTICS, INC. (PLRX)